Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Oportuzumab (Anti-EpCAM / TROP1 / CD326) For research use only.
Not for use in humans.

Oportuzumab (Anti-EpCAM / TROP1 / CD326)

Synonyms: VB4-845

Oportuzumab (Anti-EpCAM / TROP1 / CD326) is a humanized monoclonal antibody targeting EpCAM. It exhibits potential in treatment of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder. MW :145.4 KD.

Oportuzumab (Anti-EpCAM / TROP1 / CD326)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Oportuzumab (Anti-EpCAM / TROP1 / CD326) is a humanized monoclonal antibody targeting EpCAM. It exhibits potential in treatment of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder. MW :145.4 KD.

Product Details

CAS No. 945228-48-8
Molecular Weight 145.4
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Oportuzumab (Anti-EpCAM / TROP1 / CD326) | Oportuzumab (Anti-EpCAM / TROP1 / CD326) supplier | purchase Oportuzumab (Anti-EpCAM / TROP1 / CD326) | Oportuzumab (Anti-EpCAM / TROP1 / CD326) cost | Oportuzumab (Anti-EpCAM / TROP1 / CD326) manufacturer | order Oportuzumab (Anti-EpCAM / TROP1 / CD326) | Oportuzumab (Anti-EpCAM / TROP1 / CD326) distributor